IFNA1 and neoplasm: Ex-vivo-generated HPL-IFN-DCs can be furnished with tumor antigens exploiting their antigen-specific qualities in Figure 3; therefore, it is possible that HPL-IFN-DCs expressing PD-L1 would improve potency to promote cytotoxic and long-lasting immunity under immunosuppressive regulation.